Andrew C. Larner
Impact in
- Immunology top 0.5%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions
Papers in
- Immunology 54
- interferon and immune responses 31
- Immune Cell Function and Interaction 10
- Immune Response and Inflammation 8
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Oncology 63
- Cytokine Signaling Pathways and Interactions 63
- Co-authors
- Michael DavidD S FinbloomChristin Carter‐SuJames DarnellDavid T. LevyRichard JoveChao‐Lan YuDebra J. Meyer
- Journals
- Journal of Biological Chemistry (28 papers)Molecular and Cellular Biology (14 papers)The Journal of Immunology (5 papers)Science (5 papers)Blood (3 papers)
- Partner nations
- United StatesGermanyPoland
In The Last Decade
Andrew C. Larner
94 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 3.8k
- Oncology 4.6k
- Cancer Research 1.1k
- Molecular Biology 3.9k
- Pharmacology 437
Countries citing papers authored by Andrew C. Larner
This map shows the geographic impact of Andrew C. Larner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew C. Larner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew C. Larner more than expected).
Fields of papers citing papers by Andrew C. Larner
This network shows the impact of papers produced by Andrew C. Larner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew C. Larner. The network helps show where Andrew C. Larner may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew C. Larner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 17 | |
| 2 | 2012 | 91 | |
| 3 | 2011 | 13 | |
| 4 | 2010 | 86 | |
| 5 | Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation Hit paper breakdown → | 2009 | 580 |
| 6 | 2006 | 34 | |
| 7 | 2005 | 10 | |
| 8 | 2003 | 11 | |
| 9 | 2001 | 51 | |
| 10 | 2000 | 96 | |
| 11 | 2000 | 111 | |
| 12 | 1998 | 97 | |
| 13 | 1998 | 71 | |
| 14 | 1997 | 98 | |
| 15 | 1997 | 74 | |
| 16 | 1996 | 148 | |
| 17 | 1993 | 19 | |
| 18 | 1990 | 7 | |
| 19 | 1988 | 4 | |
| 20 | 1988 | 4 |
About Andrew C. Larner
Andrew C. Larner is a scholar working on Immunology, Oncology, Toxicology, Cancer Research and Molecular Biology, having authored 96 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (63 papers), interferon and immune responses (31 papers), Protein Tyrosine Phosphatases (13 papers), NF-κB Signaling Pathways (13 papers), Immune Cell Function and Interaction (10 papers), Protein Kinase Regulation and GTPase Signaling (9 papers), Immune Response and Inflammation (8 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers). The work is most often cited by research in Immunology (3.8k citations), Oncology (4.6k citations), Cancer Research (1.1k citations), Molecular Biology (3.9k citations) and Pharmacology (437 citations). Andrew C. Larner has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Michael David, D S Finbloom, Christin Carter‐Su, James Darnell, David T. Levy, Richard Jove, Chao‐Lan Yu, Debra J. Meyer, George S. Campbell and Jessica Schwartz. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, The Journal of Immunology, Science and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.